Magic Hour
You are here:  Home  >  Biotech  >  Current Article

Inogen beats expectations and stock soars

By   /   Tuesday, November 5th, 2019  /   Comments Off on Inogen beats expectations and stock soars

    Print       Email
Revenue and net income declined for Goleta-based Inogen in the third quarter, but the results outpaced analyst expectations, sending the stock up 9.5 percent in after-hours trading to $65. The oxygen concentrator developer reported $91.8 million in revenue, edging past average analyst estimates, while earnings per share of 31 cents blew past forecasts of 23…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Mindbody to buy billion-dollar fitness company, fueling talk of new IPO

Read More →